• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » More Start-Up Automation Needed to Accelerate Trials

More Start-Up Automation Needed to Accelerate Trials

August 31, 2020

Clinical trial professionals agree that study startup, which takes up 61 percent of a trial’s timeline, needs to be streamlined but most still are using manual processes rather than automated systems that can accelerate the timeline, according to a new survey.

Respondents to a recent Veeva survey favored automating startup processes like contracting and budgeting (63 percent) and collecting essential site documents (61 percent). But 81 percent of the 524 respondents reported that they still use spreadsheets and manual methods of information exchange to manage such tasks to some extent.

Approximately 50 percent of respondents said they also use electronic trial master file and clinical trial management systems, while 30 percent said they use online survey tools, 24 percent use purpose-built startup applications and site portals, and 22 percent use internally developed systems.

More strategies are needed to reduce delays, especially for trials starting during and after the COVID-19 pandemic, the survey concludes. The biggest startup challenges reported by respondents were site contracting and budgeting (68 percent), site identification, feasibility and selection (55 percent), IRB approval and planning (46 percent), site essential document collection (44 percent), and regulatory and SOP compliance (26 percent).

Overall, respondents said they use an average of three tools — manual or automated — to manage study startup activities.

To read the study, click here: https://bit.ly/32Aa6xN.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing